Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients.
|
Science
|
1998
|
4.24
|
2
|
Selection of a human T helper type 1-like T cell subset by mycobacteria.
|
J Exp Med
|
1991
|
3.41
|
3
|
Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10.
|
J Infect Dis
|
2000
|
2.70
|
4
|
Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.
|
Nature
|
1986
|
2.59
|
5
|
Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides.
|
Infect Immun
|
2000
|
2.29
|
6
|
Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent.
|
Protein Expr Purif
|
2000
|
2.00
|
7
|
Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
|
Nature
|
1994
|
1.79
|
8
|
Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
|
Nature
|
1986
|
1.69
|
9
|
Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells.
|
Eur J Immunol
|
1997
|
1.60
|
10
|
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
|
Infect Immun
|
2001
|
1.60
|
11
|
Molecular and immunological analysis of a fibronectin-binding protein antigen secreted by Mycobacterium leprae.
|
Mol Microbiol
|
1992
|
1.59
|
12
|
HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
|
Curr Biol
|
1997
|
1.57
|
13
|
Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis.
|
J Infect Dis
|
2001
|
1.56
|
14
|
Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate.
|
Eur J Immunol
|
1996
|
1.52
|
15
|
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
|
J Immunol
|
2000
|
1.48
|
16
|
Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
|
Clin Diagn Lab Immunol
|
2001
|
1.45
|
17
|
Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis?
|
Lancet
|
1986
|
1.43
|
18
|
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
|
J Exp Med
|
1989
|
1.39
|
19
|
Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
|
J Immunol
|
1993
|
1.33
|
20
|
Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
|
J Immunol
|
1992
|
1.27
|
21
|
Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels.
|
Eur J Immunol
|
1993
|
1.26
|
22
|
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
|
Int J Cancer
|
2001
|
1.25
|
23
|
High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers.
|
Science
|
1992
|
1.18
|
24
|
Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
|
J Exp Med
|
1986
|
1.18
|
25
|
Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.
|
Eur J Immunol
|
1990
|
1.18
|
26
|
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.
|
J Immunol
|
1994
|
1.14
|
27
|
T cell epitopes on the 36K and 65K Mycobacterium leprae antigens defined by human T cell clones.
|
Eur J Immunol
|
1988
|
1.13
|
28
|
Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxin-thioredoxin reductase gene.
|
Infect Immun
|
1997
|
1.10
|
29
|
Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.
|
Proc Natl Acad Sci U S A
|
1998
|
1.10
|
30
|
HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ.
|
Hum Immunol
|
1985
|
1.10
|
31
|
Uncommon presentations of tuberculosis: the potential value of a novel diagnostic assay based on the Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10.
|
Int J Tuberc Lung Dis
|
2001
|
1.10
|
32
|
Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.
|
J Exp Med
|
2000
|
1.09
|
33
|
Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy.
|
Scand J Immunol
|
1988
|
1.08
|
34
|
Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10.
|
Blood
|
2000
|
1.07
|
35
|
Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates.
|
J Exp Med
|
1993
|
1.04
|
36
|
Identification of Mycobacterium leprae antigens from a cosmid library: characterization of a 15-kilodalton antigen that is recognized by both the humoral and cellular immune systems in leprosy patients.
|
Infect Immun
|
1991
|
1.04
|
37
|
[Research into new methods for diagnosing, treating and preventing tuberculosis].
|
Ned Tijdschr Geneeskd
|
2003
|
1.02
|
38
|
Immunological and functional characterization of Mycobacterium leprae protein antigens: an overview.
|
Mol Microbiol
|
1995
|
1.01
|
39
|
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules.
|
J Immunol
|
1999
|
1.00
|
40
|
A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
|
J Immunol
|
1991
|
1.00
|
41
|
Unresponsiveness to Mycobacterium leprae in lepromatous leprosy in vitro: reversible or not?
|
Int J Lepr Other Mycobact Dis
|
1984
|
1.00
|
42
|
HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells.
|
Scand J Immunol
|
1986
|
0.96
|
43
|
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.
|
Cancer Res
|
1998
|
0.95
|
44
|
HLA-DR binding analysis of peptides from islet antigens in IDDM.
|
Diabetes
|
1998
|
0.92
|
45
|
Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae.
|
Immunol Cell Biol
|
2000
|
0.91
|
46
|
The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65.
|
Eur J Immunol
|
2001
|
0.91
|
47
|
Mapping of multiple HLA class II-restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein.
|
Infect Immun
|
1994
|
0.91
|
48
|
The mammalian cell entry operon 1 (mce1) of mycobacterium leprae and mycobacterium tuberculosis.
|
Microb Pathog
|
1999
|
0.91
|
49
|
Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis.
|
Infect Immun
|
1995
|
0.90
|
50
|
Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
|
Eur J Immunol
|
1992
|
0.90
|
51
|
Human suppressor T cell clones lack CD28.
|
Eur J Immunol
|
1990
|
0.90
|
52
|
HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells.
|
Scand J Immunol
|
1993
|
0.90
|
53
|
Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs.
|
Mol Immunol
|
1995
|
0.90
|
54
|
Purification and functional analysis of the Mycobacterium leprae thioredoxin/thioredoxin reductase hybrid protein.
|
J Biol Chem
|
1995
|
0.88
|
55
|
Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor.
|
Neth J Med
|
2001
|
0.88
|
56
|
HLA class-II immune response genes and products in leprosy.
|
Prog Allergy
|
1985
|
0.87
|
57
|
Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions.
|
Rheumatology (Oxford)
|
2000
|
0.87
|
58
|
Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries.
|
J Immunol
|
1998
|
0.87
|
59
|
T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
|
Eur J Immunol
|
1994
|
0.86
|
60
|
Epstein-Barr virus-transformed B cell lines present M. leprae antigens to T cells.
|
Scand J Immunol
|
1985
|
0.86
|
61
|
Human leukocyte antigens (HLA) and mycobacterial disease.
|
Springer Semin Immunopathol
|
1988
|
0.85
|
62
|
Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.
|
J Immunol
|
2001
|
0.85
|
63
|
Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule.
|
Diabetologia
|
1998
|
0.85
|
64
|
IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
|
J Immunol
|
1997
|
0.85
|
65
|
Definition of a human suppressor T-cell epitope.
|
Proc Natl Acad Sci U S A
|
1994
|
0.85
|
66
|
Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population.
|
Tissue Antigens
|
1984
|
0.84
|
67
|
A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions.
|
Proc Natl Acad Sci U S A
|
1993
|
0.84
|
68
|
HLA class II restriction repertoire of antigen-specific T cells. II. Evidence for a new restriction determinant associated with DRw52 and LB-Q1.
|
Hum Immunol
|
1985
|
0.82
|
69
|
Immunology of Leprosy: lessons from and for leprosy.
|
Int J Lepr Other Mycobact Dis
|
1994
|
0.81
|
70
|
HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
|
J Immunol
|
1999
|
0.80
|
71
|
Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
|
Immunology
|
1997
|
0.80
|
72
|
Bronchoalveolar lavage cells from sarcoidosis patients and healthy controls can efficiently present antigens.
|
J Intern Med
|
1999
|
0.79
|
73
|
Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
|
J Autoimmun
|
1998
|
0.79
|
74
|
A DR17-restricted T cell epitope from a secreted Mycobacterium tuberculosis antigen only binds to DR17 molecules at neutral pH.
|
Eur J Immunol
|
1997
|
0.78
|
75
|
HLA-DR/DQ transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential.
|
Biotherapy
|
1998
|
0.78
|
76
|
HLA class II restricted helper and suppressor clones reactive with Mycobacterium leprae.
|
Lepr Rev
|
1986
|
0.78
|
77
|
Role of the CDR1 region of the TCR beta chain in the binding to purified MHC-peptide complex.
|
Int Immunol
|
1994
|
0.78
|
78
|
Putting numbers on mycobacterium activated T cell subsets.
|
Clin Exp Immunol
|
1996
|
0.78
|
79
|
Mannose receptor mediated uptake of antigens strongly enhances HLA-class II restricted antigen presentation by cultured dendritic cells.
|
Adv Exp Med Biol
|
1997
|
0.78
|
80
|
A novel, highly efficient peptide-HLA class I binding assay using unfolded heavy chain molecules: identification of HIV-1 derived peptides that bind to HLA-A*0201 and HLA-A*0301.
|
J Immunol Methods
|
1997
|
0.78
|
81
|
Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
|
Clin Diagn Lab Immunol
|
2001
|
0.78
|
82
|
Limitations of homology searching for identification of T-cell antigens with library derived mimicry epitopes.
|
Vaccine
|
1999
|
0.77
|
83
|
Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on 65-kDa hsp of mycobacteria.
|
J Immunol
|
1990
|
0.77
|
84
|
The biologic importance of conserved major histocompatibility complex class II motifs in primates.
|
Hum Immunol
|
1993
|
0.77
|
85
|
The impact of DR3 microvariation on peptide binding: the combinations of specific DR beta residues critical to binding differ for different peptides.
|
Hum Immunol
|
1996
|
0.76
|
86
|
HLA antigens and neural reversal reactions in Ethiopian borderline tuberculoid leprosy patients.
|
Int J Lepr Other Mycobact Dis
|
1987
|
0.76
|
87
|
First International Conference on the Pathogenesis of Mycobacterial Infections: a summary.
|
Clin Infect Dis
|
1992
|
0.76
|
88
|
T cell receptor structure and function: analysis by expression of portions of isolated subunits.
|
Adv Exp Med Biol
|
1992
|
0.76
|
89
|
Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in patients with lepromatous leprosy.
|
Scand J Immunol
|
1990
|
0.75
|
90
|
Infections with non-tuberculous mycobacteria and salmonellae in patients with genetic defects in the interleukin-12/interferon-gamma-mediated pathway of macrophage activation.
|
Neth J Med
|
2001
|
0.75
|
91
|
The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
|
Lepr Rev
|
2000
|
0.75
|
92
|
Susceptibility alleles at HLA-DRB1, -DQA1, and -DQB1 loci in Ethiopian childhood insulin-dependent diabetes mellitus.
|
Hum Immunol
|
1994
|
0.75
|
93
|
[From gene to disease; mutations in interleukin-12-receptor-beta 1- and interferon-gamma-receptor-1 lead to nontuberculous mycobacterial infections and salmonellosis].
|
Ned Tijdschr Geneeskd
|
2000
|
0.75
|
94
|
Allorecognition of artificial nerve guides filed with human Schwann cells: an in vitro piloot study.
|
Transplantation
|
2000
|
0.75
|
95
|
HLA-DR and -DQ antigens in malnutrition-related diabetes mellitus in Ethiopians: a clue to its etiology?
|
Tissue Antigens
|
1989
|
0.75
|
96
|
Antibodies to sulfatide in leprosy and leprosy reactions.
|
Am J Trop Med Hyg
|
1999
|
0.75
|
97
|
Setting a course for intervening in host-pathogen interactions.
|
Trends Immunol
|
2001
|
0.75
|
98
|
Repeatedly negative tuberculin skin tests followed by active tuberculosis in an immunocompetent individual.
|
Neth J Med
|
2001
|
0.75
|